Expanded Access, or Compassionate Use, is the use of an investigational medicine prior to regulatory approval and outside of an active clinical trial.

Vaccinex, Inc. does not currently have an Expanded Access program for any of our investigational drugs.

We understand that it is difficult for patients with serious conditions such as cancer or neurodegenerative disease to wait for approved treatments.

We believe that devoting ourselves to current and future clinical trial programs provides the best path to meet our ultimate goal of providing therapeutics to patients.

We encourage you to speak with your physician about options that may be right for you.